GenoGenix recalls Retatrutide 60mg/10mL vials due to lack of sterility assurance. All units produced with lot number GG021125-019 are affected.
Lack of Assurance of Sterility
GenoGenix has recalled all Retatrutide for Injection vials (60mg/10mL) because they may not be sterile. This could lead to infections if used improperly.
The vials may not be sterile, which could cause infections if injected. This is a serious risk for medical use but the exact mechanism isn't specified in the recall.
People who have received Retatrutide for Injection vials with lot number GG021125-019 are affected. Those using the product for medical purposes are at risk.
Check for the lot number GG021125-019 on the vial label. The product was sold by GenoGenix LLC in Boca Raton, Florida.
Look for the lot number GG021125-019 on the vial label to confirm if it's affected.
The recall states there is a lack of sterility assurance, which could lead to infections. The product is not safe to use as is.
The recall does not specify a remedy, so you should check the vial label for the lot number and contact GenoGenix for further instructions.
Check for the lot number GG021125-019 on the vial label. The product was sold by GenoGenix LLC in Boca Raton, Florida.
We’ve drafted a message you can send GenoGenix to request your refund or repair — edit it as you like.
Subject: Recall D-0093-2026 — GenoGenix GenoGenix Hello, I own a GenoGenix that is covered by recall D-0093-2026 from GenoGenix. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
